Multibic

Sodium Hydrogen Carbonate, the active ingredient in Multibic, is an electrolyte component presented as a sterile solution for intravenous use for haemodialysis and electrolyte management. Combined with magnesium chloride hexahydrate, sodium chloride and calcium chloride dihydrate, the formulation supports acid‑base balance, plasma osmolarity and essential mineral replacement during dialysis sessions.

GNH USA supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and dialysis clinics worldwide, adhering to EU GMP manufacturing standards. The product is distributed under strict quality‑assurance protocols to ensure safety and efficacy.

Multibic is used in haemodialysis to provide electrolyte and acid‑base management.

- Haemodialysis: restores electrolyte concentrations and plasma osmolarity during the procedure. - Metabolic acidosis: supplies bicarbonate to help correct acid‑base disturbances in patients undergoing dialysis. - Hypermagnesemia prevention: provides controlled magnesium levels to avoid excess during treatment.

Multibic may be associated with infusion‑related reactions and electrolyte disturbances.

Common Side Effects: - Infusion site irritation: mild pain or redness at the catheter site. - Transient hypernatremia: slight increase in serum sodium. - Mild metabolic alkalosis: temporary rise in blood pH. - Nausea or vomiting: occasional gastrointestinal discomfort.

Serious or Rare Side Effects: - Severe electrolyte imbalance: marked hypercalcemia, hypermagnesemia or hypokalemia requiring intervention. - Anaphylactic reaction: rare hypersensitivity with rash, bronchospasm or hypotension. - Cardiac arrhythmia: potentially life‑threatening rhythm disturbances linked to abrupt electrolyte shifts.

When using Multibic, clinicians should observe the following precautions to ensure patient safety.

- Electrolyte monitoring: check serum sodium, calcium, magnesium and bicarbonate levels before and after infusion. - Fluid overload risk: avoid in patients with severe heart failure or uncontrolled hypertension. - Hypercalcemia avoidance: do not administer to patients with known elevated calcium levels. - Compatibility check: ensure solution is compatible with other IV fluids and medications to prevent precipitation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Multibic can interact with certain medications and solutions; careful assessment is required.

Major Interactions (Avoid): - Calcium chloride with phosphate binders: may precipitate calcium phosphate, risking embolism. - Magnesium chloride with other magnesium salts: can cause dangerous hypermagnesemia.

Moderate Interactions (Monitor Closely): - Loop diuretics: increase renal loss of electrolytes, requiring dose adjustment. - ACE inhibitors or ARBs: may alter potassium handling, necessitating electrolyte monitoring. - NSAIDs: can affect renal function and fluid balance, increasing risk of electrolyte disturbances.